CENTRUS ENERGY CORP (LEU) AI Stock Summary

Snapshot

Centrus Energy is a profitable, cash-rich uranium enrichment company trading at a rich valuation. The business generated $448.7 million in FY 2025 revenue, up 1.5% year-over-year, with $77.8 million in net income. It holds a massive $1.96 billion in cash against $1.21 billion in debt, creating a comfortable net cash position. The company produces $31.3 million in free cash flow annually, proving it generates real cash from operations. However, the market prices this at ~51 times annual earnings, a premium multiple that reflects its unique status as the only U.S.-owned uranium enrichment platform. A concerning signal is significant dilution: the share count jumped 21.7% in the last fiscal year, from 16.4 million to 19.9 million shares, which spreads earnings thinner for existing holders.

What's Happening Right Now

• Wed 6th May '26 · Earnings & Guidance: Centrus reported Q1 2026 revenue of $76.7 million and raised full-year guidance to $450 million to $500 million, citing a $3.9 billion backlog.
• Mon 20th Apr '26 · Construction: Centrus selected Geiger Brothers as the construction contractor for its multi-billion-dollar uranium enrichment plant expansion in Ohio.
• Thu 12th Mar '26 · Partnership: The company partnered with Palantir to use AI tools for its plant expansion, identifying roughly $300 million in potential cost savings.
• Mon 9th Mar '26 · Joint Venture: Centrus and Oklo agreed to pursue a joint venture focused on deconversion services for high-assay low-enriched uranium at Centrus' Ohio site.

Ownership

Institutions hold 60.6% of the company, while insiders hold just 0.9%.

Bottom Line

Centrus Energy is a fundamentally sound business with a strong balance sheet and a clear growth path via its Ohio expansion. The recent Q1 earnings beat and raised guidance are positive signals, but the stock is already priced for success at ~51 times earnings. The 21.7% surge in share count is a red flag for existing investors, as it dilutes ownership value. With the stock sitting in the middle of its 52-week range, it is neither a deep value bargain nor a distressed risk. A reader should weigh the strategic importance of domestic uranium enrichment against the high price and dilution risk before digging deeper.